WDR64
gene geneOn this page
Also known as FLJ32978
Summary
WDR64 (WD repeat domain 64, HGNC:26570) is a protein-coding gene on chromosome 1q43, encoding WD repeat-containing protein 64 (B1ANS9).
At a glance
- GWAS associations: 8
- Clinical variants (ClinVar): 159 total
- MANE Select transcript:
NM_001367482
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:26570 |
| Approved symbol | WDR64 |
| Name | WD repeat domain 64 |
| Location | 1q43 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ32978 |
| Ensembl gene | ENSG00000162843 |
| Ensembl biotype | protein_coding |
| Entrez | 128025 |
Gene structure
Transcript identifiers
Ensembl transcripts: 8 — 3 protein_coding, 2 nonsense_mediated_decay, 2 protein_coding_CDS_not_defined, 1 retained_intron
ENST00000366552, ENST00000414635, ENST00000425826, ENST00000437684, ENST00000461971, ENST00000472717, ENST00000478331, ENST00000496914
RefSeq mRNA: 1 — MANE Select: NM_001367482
NM_001367482
CCDS: CCDS91185
Canonical transcript exons
ENST00000437684 — 28 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001325177 | 241749547 | 241749722 |
| ENSE00001385900 | 241744393 | 241744516 |
| ENSE00002214946 | 241683487 | 241683701 |
| ENSE00002221859 | 241723297 | 241723436 |
| ENSE00002255235 | 241738363 | 241738489 |
| ENSE00002288145 | 241711802 | 241711881 |
| ENSE00002303998 | 241741516 | 241741664 |
| ENSE00002317845 | 241660530 | 241660660 |
| ENSE00003472554 | 241783272 | 241783381 |
| ENSE00003477561 | 241766218 | 241766351 |
| ENSE00003478215 | 241770621 | 241770690 |
| ENSE00003486083 | 241787849 | 241788034 |
| ENSE00003499994 | 241790591 | 241790696 |
| ENSE00003510917 | 241771661 | 241771697 |
| ENSE00003518613 | 241795207 | 241795287 |
| ENSE00003525224 | 241775105 | 241775210 |
| ENSE00003537036 | 241801132 | 241802777 |
| ENSE00003543402 | 241772792 | 241772931 |
| ENSE00003571683 | 241671074 | 241671176 |
| ENSE00003576379 | 241780004 | 241780062 |
| ENSE00003591373 | 241757283 | 241757459 |
| ENSE00003604493 | 241679485 | 241679595 |
| ENSE00003640566 | 241796257 | 241796370 |
| ENSE00003660318 | 241674644 | 241674747 |
| ENSE00003674835 | 241769404 | 241769505 |
| ENSE00003746297 | 241687461 | 241687595 |
| ENSE00003918910 | 241652281 | 241652629 |
| ENSE00003922237 | 241678187 | 241678216 |
Expression profiles
Bgee: expression breadth ubiquitous, 103 present calls, max score 91.80.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0138 / max 11.9184, expressed in 3 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 9387 | 0.0138 | 3 |
Top tissues by expression
206 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| buccal mucosa cell | CL:0002336 | 91.80 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 82.65 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 77.23 | gold quality |
| left testis | UBERON:0004533 | 73.47 | gold quality |
| right testis | UBERON:0004534 | 73.36 | gold quality |
| testis | UBERON:0000473 | 71.94 | gold quality |
| sperm | CL:0000019 | 69.37 | silver quality |
| bone marrow cell | CL:0002092 | 61.47 | gold quality |
| adrenal tissue | UBERON:0018303 | 57.66 | gold quality |
| vermiform appendix | UBERON:0001154 | 53.26 | gold quality |
| upper leg skin | UBERON:0004262 | 52.71 | gold quality |
| caecum | UBERON:0001153 | 50.32 | gold quality |
| lymph node | UBERON:0000029 | 48.24 | gold quality |
| adrenal gland | UBERON:0002369 | 46.97 | gold quality |
| gall bladder | UBERON:0002110 | 46.79 | gold quality |
| prefrontal cortex | UBERON:0000451 | 46.74 | gold quality |
| right adrenal gland | UBERON:0001233 | 46.17 | gold quality |
| left adrenal gland | UBERON:0001234 | 46.01 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 45.85 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 45.72 | gold quality |
| tonsil | UBERON:0002372 | 45.64 | gold quality |
| placenta | UBERON:0001987 | 45.38 | gold quality |
| adrenal cortex | UBERON:0001235 | 45.34 | gold quality |
| bone marrow | UBERON:0002371 | 45.08 | silver quality |
| ganglionic eminence | UBERON:0004023 | 44.71 | gold quality |
| muscle layer of sigmoid colon | UBERON:0035805 | 43.53 | gold quality |
| minor salivary gland | UBERON:0001830 | 43.49 | gold quality |
| skeletal muscle tissue of rectus abdominis | UBERON:0004511 | 43.37 | gold quality |
| frontal cortex | UBERON:0001870 | 43.29 | gold quality |
| saliva-secreting gland | UBERON:0001044 | 43.24 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 2.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-GEOD-75367 | yes | 9.73 |
| E-ANND-3 | yes | 6.31 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
87 targeting WDR64, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-30A-5P | 100.00 | 76.31 | 3233 |
| HSA-MIR-30B-5P | 100.00 | 76.29 | 3248 |
| HSA-MIR-30C-5P | 100.00 | 76.29 | 3248 |
| HSA-MIR-30D-5P | 100.00 | 76.32 | 3233 |
| HSA-MIR-30E-5P | 100.00 | 76.32 | 3242 |
| HSA-MIR-340-5P | 100.00 | 72.50 | 4437 |
| HSA-MIR-126-5P | 100.00 | 72.71 | 3180 |
| HSA-MIR-4795-3P | 100.00 | 74.62 | 4024 |
| HSA-MIR-518D-5P | 100.00 | 67.51 | 979 |
| HSA-MIR-518E-5P | 100.00 | 67.66 | 954 |
| HSA-MIR-518F-5P | 100.00 | 67.51 | 979 |
| HSA-MIR-519A-5P | 100.00 | 67.66 | 954 |
| HSA-MIR-519B-5P | 100.00 | 67.66 | 954 |
| HSA-MIR-519C-5P | 100.00 | 67.66 | 954 |
| HSA-MIR-520C-5P | 100.00 | 67.51 | 979 |
| HSA-MIR-522-5P | 100.00 | 67.66 | 954 |
| HSA-MIR-523-5P | 100.00 | 67.66 | 954 |
| HSA-MIR-526A-5P | 100.00 | 67.51 | 979 |
| HSA-MIR-3185 | 99.99 | 68.12 | 1959 |
| HSA-MIR-196A-1-3P | 99.99 | 72.15 | 2772 |
| HSA-MIR-4482-3P | 99.98 | 72.50 | 3147 |
| HSA-MIR-1250-3P | 99.96 | 70.04 | 4038 |
| HSA-MIR-9718 | 99.94 | 68.91 | 918 |
| HSA-MIR-106A-5P | 99.90 | 73.94 | 2683 |
| HSA-MIR-153-5P | 99.89 | 73.86 | 6317 |
| HSA-MIR-17-5P | 99.89 | 73.83 | 2665 |
| HSA-MIR-6780A-5P | 99.88 | 66.69 | 2776 |
| HSA-MIR-20B-5P | 99.88 | 74.01 | 2621 |
| HSA-MIR-519D-3P | 99.88 | 73.97 | 2607 |
| HSA-MIR-93-5P | 99.88 | 73.98 | 2606 |
Cross-species orthologs
5 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | si:ch211-154o6.3 | ENSDARG00000099846 |
| mus_musculus | Wdr64 | ENSMUSG00000026523 |
| rattus_norvegicus | Wdr64 | ENSRNOG00000038083 |
| drosophila_melanogaster | WDY | FBGN0267449 |
| caenorhabditis_elegans | WBGENE00004767 |
Paralogs (14): WDR54 (ENSG00000005448), FBXW11 (ENSG00000072803), FBXW7 (ENSG00000109670), TRAF7 (ENSG00000131653), FBXW9 (ENSG00000132004), FBXO36 (ENSG00000153832), FBXW12 (ENSG00000164049), BTRC (ENSG00000166167), WDR49 (ENSG00000174776), FBXW8 (ENSG00000174989), PAAF1 (ENSG00000175575), WDR86 (ENSG00000187260), FBXO16 (ENSG00000214050), EFCAB8 (ENSG00000215529)
Protein
Protein identifiers
WD repeat-containing protein 64 — B1ANS9 (reviewed: B1ANS9)
All UniProt accessions (5): A0A0A0MSY1, A0A0A0MTD4, A0A0C4DG52, B1ANS9, H0Y6L4
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| B1ANS9-1 | 1 | yes |
| B1ANS9-2 | 2 |
RefSeq proteins (1): NP_001354411* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001680 | WD40_rpt | Repeat |
| IPR015943 | WD40/YVTN_repeat-like_dom_sf | Homologous_superfamily |
| IPR036322 | WD40_repeat_dom_sf | Homologous_superfamily |
| IPR051242 | WD-EF-hand_domain | Family |
Pfam: PF00400
UniProt features (25 total): repeat 14, compositionally biased region 3, region of interest 2, sequence variant 2, sequence conflict 2, chain 1, splice variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-B1ANS9-F1 | 70.20 | 0.24 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 55 (showing top):
GSE45365_NK_CELL_VS_CD8_TCELL_DN, ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_UP, TGACATY_UNKNOWN, chr1q43, BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_B, ZWANG_TRANSIENTLY_UP_BY_2ND_EGF_PULSE_ONLY, ZNF184_TARGET_GENES, GSE10240_CTRL_VS_IL17_AND_IL22_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_DN, MIR4795_3P, MIR340_5P, MIR30B_5P_MIR30C_5P, MIR30D_5P, MIR30E_5P, MIR30A_5P, MIR5582_3P
GO Biological Process (0):
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (0):
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| binding | 1 |
Protein interactions and networks
STRING
316 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| WDR64 | CCDC30 | Q5VVM6 | 617 |
| WDR64 | OPN3 | Q9H1Y3 | 582 |
| WDR64 | NAGPA | Q9UK23 | 574 |
| WDR64 | RGS7 | P49802 | 520 |
| WDR64 | UXS1 | Q8NBZ7 | 517 |
| WDR64 | CA10 | Q9NS85 | 508 |
| WDR64 | PLD5 | Q8N7P1 | 499 |
| WDR64 | ST6GAL2 | Q96JF0 | 481 |
| WDR64 | RERE | Q9P2R6 | 476 |
| WDR64 | HMGXB4 | Q9UGU5 | 458 |
| WDR64 | TTLL7 | Q6ZT98 | 433 |
| WDR64 | CHST6 | Q9GZX3 | 433 |
| WDR64 | TMEM108 | Q6UXF1 | 430 |
| WDR64 | APEX2 | Q9UBZ4 | 426 |
| WDR64 | ZNF488 | Q96MN9 | 418 |
IntAct
2 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| MST1R | SHTN1 | psi-mi:“MI:2364”(proximity) | 0.270 |
BioGRID (17): WDR64 (Proximity Label-MS), WDR64 (Affinity Capture-MS), WDR64 (Proximity Label-MS), SNX8 (Cross-Linking-MS (XL-MS)), STK11 (Cross-Linking-MS (XL-MS)), POLD3 (Cross-Linking-MS (XL-MS)), PDE4B (Cross-Linking-MS (XL-MS)), CENPF (Cross-Linking-MS (XL-MS)), TCEA1 (Cross-Linking-MS (XL-MS)), F8 (Cross-Linking-MS (XL-MS)), NDC80 (Cross-Linking-MS (XL-MS)), ENO1 (Cross-Linking-MS (XL-MS)), COL11A2 (Cross-Linking-MS (XL-MS)), CIAPIN1 (Cross-Linking-MS (XL-MS)), DNAH5 (Cross-Linking-MS (XL-MS))
ESM2 similar proteins: A0A0G2JEB6, A0JM56, B0DOB4, B0FXQ5, B1ANS9, B4F7L9, B4GQJ7, B5DHW4, B7FF06, B7FF07, B7FF08, B7FF09, B7FF12, C5IAW9, F1LW30, F1P4W9, O08747, O95185, P0DM40, Q008S8, Q18264, Q32NR9, Q3V0B4, Q402B2, Q4G0P3, Q5R4M2, Q5T0N1, Q5XI14, Q6AXU1, Q6DCF6, Q6NRS1, Q6P2C0, Q6P5D8, Q6UXZ4, Q6ZTR5, Q6ZU64, Q761X5, Q7T2Z5, Q80W93, Q86YR7
Diamond homologs: B1ANS9, Q9D565, Q8IV35
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
159 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 148 |
| Likely benign | 3 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
4400 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 1:241723432:CAAAG:C | donor_loss | 1.0000 |
| 1:241723433:AAAGG:A | donor_loss | 1.0000 |
| 1:241723435:AG:A | donor_loss | 1.0000 |
| 1:241723436:GGTA:G | donor_loss | 1.0000 |
| 1:241723437:G:T | donor_loss | 1.0000 |
| 1:241723438:T:A | donor_loss | 1.0000 |
| 1:241738357:TTCCA:T | acceptor_loss | 1.0000 |
| 1:241738358:TCCA:T | acceptor_loss | 1.0000 |
| 1:241738359:CCA:C | acceptor_loss | 1.0000 |
| 1:241738360:CAGGT:C | acceptor_loss | 1.0000 |
| 1:241738361:AGGT:A | acceptor_loss | 1.0000 |
| 1:241738362:G:GC | acceptor_loss | 1.0000 |
| 1:241738487:CGGG:C | donor_loss | 1.0000 |
| 1:241738488:GG:G | donor_gain | 1.0000 |
| 1:241738488:GGGTA:G | donor_loss | 1.0000 |
| 1:241738489:GG:G | donor_gain | 1.0000 |
| 1:241738489:GGTAA:G | donor_loss | 1.0000 |
| 1:241738490:G:C | donor_loss | 1.0000 |
| 1:241738490:G:GG | donor_gain | 1.0000 |
| 1:241738491:T:G | donor_loss | 1.0000 |
| 1:241741663:GG:G | donor_gain | 1.0000 |
| 1:241741664:GG:G | donor_gain | 1.0000 |
| 1:241741665:G:GG | donor_gain | 1.0000 |
| 1:241744481:A:T | donor_gain | 1.0000 |
| 1:241744506:A:T | donor_gain | 1.0000 |
| 1:241757457:GAT:G | donor_gain | 1.0000 |
| 1:241766212:CTTCA:C | acceptor_loss | 1.0000 |
| 1:241766213:TTCA:T | acceptor_loss | 1.0000 |
| 1:241766214:TCA:T | acceptor_loss | 1.0000 |
| 1:241766215:CA:C | acceptor_loss | 1.0000 |
AlphaMissense
7268 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 1:241723419:A:C | S383R | 1.000 |
| 1:241723421:C:A | S383R | 1.000 |
| 1:241723421:C:G | S383R | 1.000 |
| 1:241683583:G:T | G231W | 0.999 |
| 1:241723320:T:A | W350R | 0.999 |
| 1:241723320:T:C | W350R | 0.999 |
| 1:241738375:T:A | W393R | 0.999 |
| 1:241738375:T:C | W393R | 0.999 |
| 1:241679540:C:A | A180D | 0.998 |
| 1:241683578:T:C | L229P | 0.998 |
| 1:241683583:G:A | G231R | 0.998 |
| 1:241683583:G:C | G231R | 0.998 |
| 1:241683584:G:A | G231E | 0.998 |
| 1:241683596:G:A | G235D | 0.998 |
| 1:241687490:T:A | V280D | 0.998 |
| 1:241723315:G:C | R348P | 0.998 |
| 1:241674710:C:A | A149D | 0.997 |
| 1:241679494:T:A | W165R | 0.997 |
| 1:241679494:T:C | W165R | 0.997 |
| 1:241679531:G:C | R177P | 0.997 |
| 1:241687531:T:C | S294P | 0.997 |
| 1:241711873:T:A | V339D | 0.997 |
| 1:241738370:G:C | R391P | 0.997 |
| 1:241738377:G:C | W393C | 0.997 |
| 1:241738377:G:T | W393C | 0.997 |
| 1:241787853:T:A | W894R | 0.997 |
| 1:241787853:T:C | W894R | 0.997 |
| 1:241679539:G:C | A180P | 0.996 |
| 1:241679566:T:A | W189R | 0.996 |
| 1:241679566:T:C | W189R | 0.996 |
dbSNP variants (sampled 300 via entrez): RS1000009151 (1:241770030 G>A), RS1000014180 (1:241727587 T>G), RS1000035176 (1:241681142 T>C), RS1000066395 (1:241727310 T>C), RS1000093510 (1:241693085 C>T), RS1000133265 (1:241774767 A>C), RS1000188043 (1:241704300 A>G), RS1000188555 (1:241762572 A>T), RS1000212155 (1:241674724 T>A,C), RS1000218609 (1:241715890 T>C), RS1000265230 (1:241722113 T>G), RS1000284205 (1:241692882 A>G), RS1000293949 (1:241768534 G>A), RS1000348785 (1:241714706 G>T), RS1000374073 (1:241756486 G>A)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
8 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST000823_5 | Radiation response | 2.000000e-06 |
| GCST002133_8 | Illicit drug use | 3.000000e-06 |
| GCST007666_2 | Depressive symptom improvement | 4.000000e-07 |
| GCST007667_6 | Treatment resistant depression | 9.000000e-07 |
| GCST009391_1065 | Metabolite levels | 4.000000e-06 |
| GCST010249_4 | Chronic obstructive pulmonary disease | 6.000000e-06 |
| GCST010396_74 | Gut microbiota (bacterial taxa, hurdle binary method) | 9.000000e-06 |
| GCST012490_334 | Femur bone mineral density x serum urate levels interaction | 2.000000e-09 |
EFO canonical traits (6, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0005431 | illegal drug consumption |
| EFO:0007006 | depressive symptom measurement |
| EFO:0009854 | treatment resistant depression |
| EFO:0010364 | lysophosphatidylcholine 20:5 measurement |
| EFO:0007874 | gut microbiome measurement |
| EFO:0004531 | urate measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
6 total (human), top 6 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| tungsten carbide | decreases expression, affects binding | 1 |
| cobaltous chloride | increases expression | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| Cobalt | affects binding, decreases expression | 1 |
| Methotrexate | increases expression | 1 |
| Aflatoxin B1 | decreases methylation | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.